Zofran Birth Defect Lawsuits Increase As New Filing Forms Are Proposed

   

Zofran Birth Defect Lawsuits Alleging Anti-Nauseau Drug Causes Birth Defects Including Cleft Lip, Cleft Palate, and Heart Murmurs

Zofran-birth-defects-lawsuit-lawyer-attorney-9The number of Zofran birth defects lawsuits alleging babies suffer birth defects after exposure to Zofran continue to increase in the U.S. Court, District of Massachusetts. Court documents show that 260 Zofran birth defects lawsuits are pending in the multidistrict litigation (MDL), an additional 13 complaints since April when 247 Zofran birth defects lawsuit claims were pending in the MDL.The Zofran birth defects lawsuit complaints allege that GlaxoSmithKline, the maker of Zofran, improperly promoted the anti-nausea drug as a treatment for morning sickness in pregnant women but failed to disclose that Zofran allegedly causes such birth defects as cleft palate, cleft lip, heart defects, and musculoskeletal defects. (In Re: Zofran Birth Defects Lawsuit Litigation – MDL No. 2657)

“Developing ‘Master Pleadings,’ as they are called, is a common practice in litigation involving hundreds of lawsuits that have the same or similar allegations,” says Dr. François Blaudeau, co-founder of Southern Med Law. As both an attorney and a practicing obstetrician/gynecologist, Dr. Blaudeau possesses unique insight into the various legal and medical issues at the center of Zofran birth defects cases such as those pending in Massachusetts.

Southern Med Law is currently evaluating potential Zofran birth defects lawsuits on behalf of families who believe their child was born with a birth defect due to this medication. To learn more about the litigation involving Zofran and birth defects, please contact the Firm as soon as possible. You can arrange for a free, no obligation Zofran lawsuit review by 205-547-5525 or you can visit www.southernmedlaw for more information and to fill out a contact form.

Zofran birth defects lawsuits

Zofran birth defects lawsuits will be easier to file into the MDL now that U.S. District Judge F. Dennis Saylor IV will allow plaintiffs to file a Short Form Complaint. In May, Judge Saylor ordered plaintiffs to create a Master Complaint with common allegations regarding Zofran, and ordered GlaxoSmithKline to serve and file a Master Answer by June 21. From the Master Complaint, plaintiffs will choose allegations to include in their Short Form Complaint along with their personal details. The plaintiffs have until June 10 to create a Short Form Complaint and submit it to Judge Saylor for approval. Within 30 days after the court approves the document, each plaintiff must file a Short Form Complaint. (In Re: Zofran (Ondansetron) Products Liability Litigation – MDL No. 2657)

Zofran Side-Effect Studies

Studies show that Zofran use during pregnancy places newborns at risk for congenital defects. One study conducted by Swedish researchers involved 1,349 infants whose mothers took ondansetron in early pregnancy. Researchers found a 62 percent increased risk in cardiovascular defects, most notably a cardiac septum defect. Zofran (ondansetron) is approved by the U.S. Food and Drug Administration (FDA) to treat nausea and vomiting in cancer patients under going chemotherapy and radiation and for patients who have undergone surgery.
[ncbi.nlm.nih.gov/pubmed/25450422, Reproductive Toxicology, December 2014]

Plaintiffs in the Zofran MDL contend that the FDA did not approve Zofran to treat morning sickness, yet GlaxoSmithKline marketed the drug for that use to expectant mothers. The company was investigated by the U.S. Department of Justice for its off-label promotion of Zofran. In June 2012, GlaxoSmithKline agreed to pay $3 billion to resolve civil and criminal claims of improperly marketing Zofran and its other drugs for uses that were not FDA-approved.
[justice.gov/opa/pr/glaxosmithkline-plead-guilty-and-pay-3-billion-resolve-fraud-allegations-and-failure-report,DOJ, June 2012]

About Southern Med Law and Filing A Zofran Birth Defect Lawsuit

Southern Med Law is an experienced law firm providing legal representation individuals across the country who have been victims of negligent personal injuries, medical malpractice, dangerous drugs, faulty medical devices and defective products. Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in all manner of product liability and personal injury claims. They’re not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.

Contact:
Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525

Fax: 205-547-5526
francois@southernmedlaw.com
http://www.southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam

This entry was posted in Southern Med Law | Article. Bookmark the permalink.